Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | F11 | P03951 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 2/20 | 0.38 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.38 |
| ▸ | CMA1 | P23946 | 1/20 | 0.38 |
| ▸ | F7 | P08709 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | F3 | P13726 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8147513 | 0.84 | CYP3A4 (0.59) | CYP2A6CYP3A4POLBNR4A2TP53 | |
| SCHEMBL8149283 | 0.84 | CYP2A6 (0.46) | CYP2A6CYP3A4POLBCYP1A2TP53 | |
| SCHEMBL8149293 | 0.84 | CYP2A6 (0.46) | CYP2A6CYP3A4POLBCYP1A2TP53 | |
| SCHEMBL8148704 | 0.84 | CYP2A6 (0.46) | CYP2A6CYP3A4POLBCYP1A2F11 | |
| SCHEMBL8150232 | 0.84 | CYP3A4 (0.59) | CYP2A6CYP3A4POLBNR4A2TP53 | |
| SCHEMBL8289896 | 0.84 | CYP2A6 (0.46) | CYP2A6CYP3A4POLBCYP1A2F11 | |
| SCHEMBL8337554 | 0.84 | CYP2A6 (0.46) | CYP2A6CYP3A4POLBCYP1A2F11 | |
| SCHEMBL31665941 | 0.83 | CYP2A6 (0.68) | CYP2A6CYP3A4F11AHRNR4A2 | |
| SCHEMBL11302716 | 0.83 | CYP2A6 (0.68) | CYP2A6CYP3A4F11AHRNR4A2 | |
| SCHEMBL4288341 | 0.83 | CYP2A6 (0.68) | CYP2A6CYP3A4F11AHRNR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7884249-B2 | oxidizing a diol derivative with an oxidizing agent such as osmium tetraoxide to form 6,13-ethanopentacene-6,13-dione | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-7884249-B2 | oxidizing a diol derivative with an oxidizing agent such as osmium tetraoxide to form 6,13-ethanopentacene-6,13-dione | CANON KABUSHIKI KAISHA (JP) | 2011-02-08 | — | — | US | disclosed |
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-12-24 | — | — | US | disclosed |
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2009-12-24 | — | — | US | disclosed |
| US-7601478-B2 | Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same | CANON KABUSHIKI KAISHA (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7601478-B2 | Bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same | CANON KABUSHIKI KAISHA (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7588959-B2 | Organic field effect transistor and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
| US-7588959-B2 | Organic field effect transistor and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
| US-20070135428-A1 | LACTAM CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS | QIAO JENNIFER X | 2007-06-14 | — | — | US | disclosed |
| WO-2006041831-A2 | CYCLIC Β-AMINO ACID DERIVATIVES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-04-20 | — | — | WO | disclosed |
| WO-2005032490-A2 | CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-04-14 | — | — | WO | disclosed |
| WO-2005032468-A2 | MONOCYCLIC AND BICYCLIC LACTAMS AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-04-14 | — | — | WO | disclosed |
| WO-2004082687-A1 | LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-09-30 | — | — | WO | disclosed |
| WO-2003099276-A1 | 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090317753-A1 | BICYCLO COMPOUND, METHOD FOR PRODUCING PENTACENE AND A FILM THEREOF USING THE SAME, AND METHOD FOR PRODUCING BICYCLO COMPOUND | C9, C5, RNF168 | CYP2A6 1084/4885CYP3A4 154/4885POLB 2724/4885 |
| US-20070135428-A1 | LACTAM CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS | F12, F2, PEPD | CYP2A6 2113/4885CYP3A4 1311/4885POLB 2080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.